dc.contributor.author | Ozekmekci, S | |
dc.contributor.author | Apaydin, Hülya | |
dc.contributor.author | Altinel, Ahmet | |
dc.contributor.author | Vural, M | |
dc.date.accessioned | 2021-03-05T12:31:42Z | |
dc.date.available | 2021-03-05T12:31:42Z | |
dc.date.issued | 2003 | |
dc.identifier.citation | Vural M., Ozekmekci S., Apaydin H., Altinel A., "High-dose piracetam is effective on cerebellar ataxia in a patient with cerebellar cortical atrophy", MOVEMENT DISORDERS, cilt.18, ss.457-459, 2003 | |
dc.identifier.issn | 0885-3185 | |
dc.identifier.other | av_ad990b05-4a8a-4e23-ba1e-b7836c346e51 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/115823 | |
dc.identifier.uri | https://doi.org/10.1002/mds.10364 | |
dc.description.abstract | We describe a patient with cerebellar ataxia of degenerative nature who was administered high-dose piracetam in a single-blind trial. Piracetam was demonstrated to be highly effective on tandem gait and gait ataxia in daily doses of 60 g. We suggest piracetam has a potential anti-ataxic effect in human cerebellar ataxia when used in considerably higher doses than those indicated for other purposes. (C) 2003 Movement Disorder Society. | |
dc.language.iso | eng | |
dc.subject | Nöroloji | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | KLİNİK NEUROLOJİ | |
dc.title | High-dose piracetam is effective on cerebellar ataxia in a patient with cerebellar cortical atrophy | |
dc.type | Makale | |
dc.relation.journal | MOVEMENT DISORDERS | |
dc.contributor.department | , , | |
dc.identifier.volume | 18 | |
dc.identifier.issue | 4 | |
dc.identifier.startpage | 457 | |
dc.identifier.endpage | 459 | |
dc.contributor.firstauthorID | 21989 | |